SEC Form 4 · accession 0001209191-15-076490
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward M. Kaye M.D.
Officer — SVP Interim CEO & CMO
Period of report
Oct 20, 2015
Accepted (ET)
Oct 22, 2015 · 6:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 20, 2015 | F | 3,001 | $26.74 | D | 106,893 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of restricted stock.
- F2Includes shares purchased under the Company's employee stock purchase plan prior to the reported transaction.